Cost-effectiveness analysis of parenteral iron therapy compared to oral iron supplements in managing iron deficiency anemia among pregnant women

Springer Science and Business Media LLC - Tập 14 - Trang 1-11 - 2024
Somen Saha1, Devang Raval1, Komal Shah1, Deepak Saxena1
1Indian Institute of Public Health, Gandhinagar, India

Tóm tắt

This study compared the clinical efficacy and cost-effectiveness of parenteral iron, using intravenous iron sucrose (IVIS) therapy against the standard regimen of oral iron (OI) therapy for managing iron-deficiency anemia (IDA) among pregnant women in a natural primary care setting in Gujarat. A prospective cost-effectiveness study was conducted in natural programme setting wherein 188 pregnant women in their 14 to 18 weeks with moderate and severe anemia women enrolled from two districts of Gujarat, and 142 were followed up until the post-partum phase. The intervention group comprised of 82 participants who were administered IVIS, while the comparison group comprised of 106 participants who were put on OI therapy. Hemoglobin (Hb) levels were measured at periodic intervals, first during enrollment and then during each month of pregnancy period and finally on the 42nd day of the post-natal period. Change in mean Hb level from baseline was the primary outcome, while the incidence of morbidity and mortality was a secondary outcome measure. The intervention group showed a significant incremental mean change in Hb level from 8.2 g/dl to 11.45 g/dl at the fourth follow-up, while the control group's mean Hb level reduced from 9.99 g/dl to 9.55 g/dl. The discounted cost per beneficiary for IVIS was US$ 87, while that for OI was US$ 49. The incremental cost-effectiveness ratio (ICER) was US$ 9.84, which is 0.049% of India's per capita GDP. IVIS therapy was more clinically effective and cost-effective than OI therapy among pregnant women for management of moderate and severe anemia.

Tài liệu tham khảo

Family N, Survey H. Government of India Ministry of Health and Family Welfare COMPENDIUM OF FACT SHEETS INDIA AND 14 STATES/UTs (Phase-11).

Kumari S, Garg N, Kumar A, Guru PKI, Ansari S, Anwar S, Singh KP, Kumari P, Mishra PK, Gupta BK, Nehar S, Sharma AK, Raziuddin M, Sohail M. Maternal and severe anaemia in delivering women is associated with risk of preterm and low birth weight: a cross sectional study from Jharkhand, India. One Health. 2019;8:100098. https://doi.org/10.1016/j.onehlt.2019.100098.

Bone JN, Bellad M, Goudar S, et al. Anemia and adverse outcomes in pregnancy: subgroup analysis of the CLIP cluster-randomized trial in India. BMC Pregnancy Childbirth. 2022;22:407. https://doi.org/10.1186/s12884-022-04714-y.

Jasani J, Trivedi J, Rajdev S, Pandya H. Hematological study of iron deficiency anemia in pregnancy in Central Gujarat. Int J Biomed Adv Res. 2019;10(3):7–9.

Tolkien Z, Stecher L, Mander AP, Pereira DI, Powell JJ. Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis. PLoS One. 2015;10(2):e0117383. https://doi.org/10.1371/journal.pone.0117383.

Marahatta R. Study of anaemia in pregnancy and its outcome in Nepal Medical College Teaching Hospital, Kathmandu. Nepal Nepal Med Coll J. 2007;9(4):270–4.

K. K. Prevalence & consequences of anaemia in pregnancy. Indian Journal of Medical Research. 2009;130(5):627–33.

Kriplani A, Mahey R, Dash BB, Kulshreshta V, Agarwal N, Bhatla N. Intravenous iron sucrose therapy for moderate to severe anaemia in pregnancy. Indian J Med Res. 2013;138(JUL 2013):78–82.

Neogi SB, Devasenapathy N, Singh R, Bhushan H, Shah D, Divakar H, Zodpey S, Malik S, Nanda S, Mittal P, Batra A, Chauhan MB, Yadav S, Dongre H, Saluja S, Malhotra V, Gupta A, Sangwan R, Radhika AG, Singh A, Bhaskaran S, Kotru M, Sikka M, Agarwal S, Francis P, Mwinga K, Baswal D. Safety and effectiveness of intravenous iron sucrose versus standard oral iron therapy in pregnant women with moderate-to-severe anaemia in India: a multicentre, open-label, phase 3, randomised, controlled trial. Lancet Glob Health. 2019 Dec;7(12):e1706-e1716. https://doi.org/10.1016/S2214-109X(19)30427-9. Erratum in: Lancet Glob Health. 2020;8(12):e1472.

Qassim A, Mol BW, Grivell RM, Grzeskowiak LE. Safety and efficacy of intravenous iron polymaltose, iron sucrose and ferric carboxymaltose in pregnancy: a systematic review. Aust N Z J Obstet Gynaecol. 2018;58(1):22–39.

Dubey S, Suri V, Aggarawal N, Das R. Is it safe to use intravenous iron sucrose during pregnancy? A randomized controlled trial. Int J Reprod Contracept Obstet Gynecol. 2013;2(4):544.

Rathod S, Samal S, Mahapatra P, Samal S. Ferric carboxymaltose: a revolution in the treatment of postpartum anemia in Indian women. Int J Appl Basic Med Res. 2015;5(1):25.

Rabin R, De Charro F. EQ-5D: A measure of health status from the EuroQol Group. Ann Med. 2001;33(5):337–43.

Saha S, Desai B, Fancy M, Puwar T, Saxena D, Shah K, Pandya A. Protocol for the cost-effectiveness of parenteral iron and oral iron therapy for first-line management of anaemia among pregnant women in a natural programme setting in Gujarat. BMJ Open. 2021;11(6):e044712. https://doi.org/10.1136/bmjopen-2020-044712.

EuroQoL EQ-5D-5L Index Value Calculator.

Bayoumeu F, Subiran-Buisset C, Baka NE, Legagneur H, Monnier-Barbarino P, Laxenaire MC. Iron therapy in iron deficiency anemia in pregnancy: Intravenous route versus oral route. Am J Obstet Gynecol. 2002;186(3):518–22.

Al RA, Unlubilgin E, Kandemir O, Yalvac S, Cakir L, Haberal A. Intravenous versus oral iron for treatment of anemia in pregnancy: a randomized trial. Obstet Gynecol. 2005;106(6):1335–40.

Neeru S, Nair NS, Rai L. Iron sucrose versus oral iron therapy in pregnancy anemia. Indian J Commun Med. 2012;37(4):214–8.

Kochhar PK, Kaundal A, Ghosh P. Intravenous iron sucrose versus oral iron in treatment of iron deficiency anemia in pregnancy: a randomized clinical trial. J Obstetr Gynaecol Res. 2013;39(2):504–10.

Bhavi SB, Jaju PB. Intravenous iron sucrose v/s oral ferrous fumarate for treatment of anemia in pregnancy. A randomized controlled trial. BMC Pregnancy Childbirth. 2017;17(1):137. https://doi.org/10.1186/s12884-017-1313-9.

Abhilashini GD, Sagili H, Reddi R. Intravenous iron sucrose and oral iron for the treatment of iron deficiency Anaemia in pregnancy. J Clin Diagn Res. 2014;8(5):4–7.

Panchal PJ, Desai MK, Shah SP, Solanki MN. Evaluation of efficacy, safety and cost of oral and parenteral iron preparations in patients with iron deficiency anemia. J Appl Pharm Sci. 2015;5(3):66–72.

Al RA, Unlubilgin E, Kandemir O, Yalvac S, Cakir L, Haberal A. Intravenous versus oral iron for treatment of anemia in pregnancy: A randomized trial. Obstet Gynecol. 2005;106(6):1335–40.

Sharma JB, Jain S, Mallika V, Singh T, Kumar A, Arora R, et al. A prospective, partially randomized study of pregnancy outcomes and hematologic responses to oral and intramuscular iron treatment in moderately anemic pregnant women. Am J Clin Nutr. 2004;79(1):116–22.

Kumar A, Jain S, Singh NP, Singh T. Oral versus high dose parenteral iron supplementation in pregnancy. Int J Gynecol Obstet. 2005;89(1):7–13.

Tigga M, Debbarma A. A comparative study to evaluate oral iron and intravenous iron sucrose for treatment of anemia in pregnancy in a poor socioeconomic region of Northeast India. Tzu Chi Med J. 2020;32(3):258–61.

Pollock RF, Muduma G. A patient-level cost-effectiveness analysis of iron isomaltoside versus ferric carboxymaltose for the treatment of iron deficiency anemia in the United Kingdom. J Med Econ. 2020;23(7):751–9.

Ray S, Neogi SB, Singh R, Devasenapathy N, Zodpey S. Is IV iron sucrose a cost-effective option for treatment of severe anaemia in pregnancy as compared with oral iron? Health Policy Plan. 2021;35(10):1339–46.

Department of Health Research - HTAIn [Internet]. [cited 2023 Dec 11]. https://dhr.gov.in/health-technology-assessment-india-htain. Available from: https://dhr.gov.in/sites/default/files/Policy%20Brief%20vol%202.pdf.

Thông tin
Thông tin xuất bản

Springer Science and Business Media LLC

Tập 14

1-11

Thông tin tác giả